Picture-Perfect Competition for Lymphoma Awareness

To raise awareness of the disease and to mark Worldwide Lymphoma Awareness Day on September 15, the patient support group, Lymphoma Support Ireland (LSI), has launched a competition for amateur photographers. Entitled 'Beacons of Hope', the competition aims to encourage members of the public, especially those who have been touched by cancer, to represent their 'beacons of hope' through photography.



The judging panel includes international photographer, Perry Ogden, whose photos are exhibited in galleries worldwide. Winning entries will be displayed at a special exhibition in Dublin on Worldwide Lymphoma Awareness Day.



"This is an opportunity to send a positive message to cancer patients and their families, with a focus on one of the most curable forms of malignant disease", said Professor Peter Daly, a consultant medical oncologist at St James's Hospital in Dublin.



The overall winner of the competition will receive €1,000 worth of photographic equipment, while 11 runners up will each receive a digital camera. The closing date for entries is August 17. Entries should be posted to:



Lymphoma Support Ireland

c/o Irish Cancer Society

43 - 45 Northumberland Road

Dublin 4 Or emailed to images@beaconsofhope.org



Full competition details are available at
http://www.beaconsofhope.org



I have known the Lymphoma Support Ireland folks for many years and they are a great group!

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap